Literature DB >> 34282021

Tradeoffs for a viral mutant with enhanced replication speed.

Matthew R Lanahan1, Robert W Maples1, Julie K Pfeiffer2.   

Abstract

RNA viruses exist as genetically heterogeneous populations due to high mutation rates, and many of these mutations reduce fitness and/or replication speed. However, it is unknown whether mutations can increase replication speed of a virus already well adapted to replication in cultured cells. By sequentially passaging coxsackievirus B3 in cultured cells and collecting the very earliest progeny, we selected for increased replication speed. We found that a single mutation in a viral capsid protein, VP1-F106L, was sufficient for the fast-replication phenotype. Characterization of this mutant revealed quicker genome release during entry compared to wild-type virus, highlighting a previously unappreciated infection barrier. However, this mutation also reduced capsid stability in vitro and reduced replication and pathogenesis in mice. These results reveal a tradeoff between overall replication speed and fitness. Importantly, this approach-selecting for the earliest viral progeny-could be applied to a variety of viral systems and has the potential to reveal unanticipated inefficiencies in viral replication cycles.

Entities:  

Keywords:  capsid; coxsackievirus; fitness; replication speed

Mesh:

Substances:

Year:  2021        PMID: 34282021      PMCID: PMC8325337          DOI: 10.1073/pnas.2105288118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants.

Authors:  J M Groarke; D C Pevear
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

Review 2.  Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment.

Authors:  M A McKinlay; D C Pevear; M G Rossmann
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

3.  The cost of replication fidelity in an RNA virus.

Authors:  Victoria Furió; Andrés Moya; Rafael Sanjuán
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

4.  Cutting Edge: Antibody-mediated TLR7-dependent recognition of viral RNA.

Authors:  Jennifer P Wang; Damon R Asher; Melvin Chan; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

5.  IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Ronelle A Steele; Shannon J L Gatewood; Noel R Rose
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

6.  Coxsackievirus B3 mutator strains are attenuated in vivo.

Authors:  Nina F Gnädig; Stéphanie Beaucourt; Grace Campagnola; Antonio V Bordería; Marta Sanz-Ramos; Peng Gong; Hervé Blanc; Olve B Peersen; Marco Vignuzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-01       Impact factor: 11.205

7.  Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice.

Authors:  Julie K Pfeiffer; Karla Kirkegaard
Journal:  PLoS Pathog       Date:  2005-10-07       Impact factor: 6.823

8.  Genetic variation in fitness within a clonal population of a plant RNA virus.

Authors:  Héctor Cervera; Santiago F Elena
Journal:  Virus Evol       Date:  2016-03-30

9.  Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.

Authors:  Yao Wang; Julie K Pfeiffer
Journal:  MBio       Date:  2016-03-29       Impact factor: 7.867

10.  Adaptation of influenza A (H7N9) virus in primary human airway epithelial cells.

Authors:  Daniel Tsung-Ning Huang; Chun-Yi Lu; Ya-Hui Chi; Wan-Ling Li; Luan-Yin Chang; Mei-Ju Lai; Jin-Shing Chen; Wen-Ming Hsu; Li-Min Huang
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more
  1 in total

1.  Molecular characteristics of a coxsackievirus A12 strain in Zhejiang of China, 2019.

Authors:  Linjie Hu; Lu Zhou; Pingping Wang; Hairenguli Maimaiti; Yihan Lu
Journal:  Virol J       Date:  2022-10-12       Impact factor: 5.913

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.